{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:56:32Z","timestamp":1781265392702,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"DOI":"10.7759\/cureus.110726","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:03:28Z","timestamp":1781262208000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Lack of Association Between Preoperative Hormone Replacement Therapy and Increased Venous Thromboembolism After Arthroscopic Orthopedic Surgery"],"prefix":"10.7759","author":[{"given":"Ronak J","family":"Mahatme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Gangavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanth","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K","family":"Gerak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Bernholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Grawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002335","article-title":"Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses","volume":"31","author":"Baik SH","year":"2024","unstructured":"Baik SH, Baye F, McDonald CJ. Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses. Menopause. 2024, 31:363-71. 10.1097\/GME.0000000000002335","journal-title":"Menopause"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.11.005","article-title":"Testosterone replacement therapy in hypogonadal men","volume":"51","author":"Wang C","year":"2022","unstructured":"Wang C, Swerdloff RS. Testosterone replacement therapy in hypogonadal men. Endocrinol Metab Clin North Am. 2022, 51:77-98. 10.1016\/j.ecl.2021.11.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.10.016","article-title":"Marketing and testosterone treatment in the USA: a systematic review","volume":"3","author":"Bandari J","year":"2017","unstructured":"Bandari J, Ayyash OM, Emery SL, Wessel CB, Davies BJ. Marketing and testosterone treatment in the USA: a systematic review. Eur Urol Focus. 2017, 3:395-402. 10.1016\/j.euf.2017.10.016","journal-title":"Eur Urol Focus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001066","article-title":"Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey","volume":"25","author":"Pacello P","year":"2018","unstructured":"Pacello P, Baccaro LF, Pedro AO, Costa-Paiva L. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey. Menopause. 2018, 25:683-90. 10.1097\/GME.0000000000001066","journal-title":"Menopause"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.3128","article-title":"Menopausal hormone therapy use among postmenopausal women","volume":"5","author":"Yang L","year":"2024","unstructured":"Yang L, Toriola AT. Menopausal hormone therapy use among postmenopausal women. JAMA Health Forum. 2024, 5:e243128. 10.1001\/jamahealthforum.2024.3128","journal-title":"JAMA Health Forum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000744","article-title":"Trends and patterns of testosterone therapy among U.S. male Medicare beneficiaries, 1999 to 2014","volume":"203","author":"Zhou CK","year":"2020","unstructured":"Zhou CK, Advani S, Chaloux M, et al.. Trends and patterns of testosterone therapy among U.S. male Medicare beneficiaries, 1999 to 2014. J Urol. 2020, 203:1184-90. 10.1097\/JU.0000000000000744","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova Y","year":"2019","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019, 364:k4810. 10.1136\/bmj.k4810","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur C","year":"2022","unstructured":"LaVasseur C, Neukam S, Kartika T, Samuelson Bannow B, Shatzel J, DeLoughery TG. Hormonal therapies and venous thrombosis: considerations for prevention and management. Res Pract Thromb Haemost. 2022, 6:e12763. 10.1002\/rth2.12763","journal-title":"Res Pract Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep15020029","article-title":"Testosterone usage leading to pulmonary embolisms and deep vein thrombosis: a case report and review of the literature","volume":"15","author":"Menakuru SR","year":"2023","unstructured":"Menakuru SR, Atta M, Dhillon VS, Salih A. Testosterone usage leading to pulmonary embolisms and deep vein thrombosis: a case report and review of the literature. Hematol Rep. 2023, 15:290-7. 10.3390\/hematolrep15020029","journal-title":"Hematol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9581605","article-title":"Waldenstr\u00f6m macroglobulinemia and cerebral venous thrombosis: from diagnosis to complication","volume":"2019","author":"Costa PZ","year":"2019","unstructured":"Costa PZ, Chor\u00e3o P, P\u00f3voa A, Vieira P, Cabrera H, Mendes O, Evangelista C. Waldenstr\u00f6m macroglobulinemia and cerebral venous thrombosis: from diagnosis to complication. Case Rep Med. 2019, 2019:9581605. 10.1155\/2019\/9581605","journal-title":"Case Rep Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-016-0207-z","article-title":"Association between hypertension and deep vein thrombosis after orthopedic surgery: a meta-analysis","volume":"21","author":"Huang L","year":"2016","unstructured":"Huang L, Li J, Jiang Y. Association between hypertension and deep vein thrombosis after orthopedic surgery: a meta-analysis. Eur J Med Res. 2016, 21:13. 10.1186\/s40001-016-0207-z","journal-title":"Eur J Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-021-00310-w","article-title":"Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women","volume":"19","author":"MacDonald CJ","year":"2021","unstructured":"MacDonald CJ, Madika AL, Lajous M, Canonico M, Fournier A, Boutron-Ruault MC. Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women. Thromb J. 2021, 19:58. 10.1186\/s12959-021-00310-w","journal-title":"Thromb J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/a-2570-4455","article-title":"Impact of hematocrit on coagulation measured by rotational thromboelastometry in healthy subjects and patients with polycythemia","volume":"52","author":"Martin M","year":"2026","unstructured":"Martin M, Nader E, Rezigue H, et al.. Impact of hematocrit on coagulation measured by rotational thromboelastometry in healthy subjects and patients with polycythemia. Semin Thromb Hemost. 2026, 52:487-94. 10.1055\/a-2570-4455","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1753944714553226","article-title":"The role of chronic hyperviscosity in vascular disease","volume":"9","author":"Sloop G","year":"2015","unstructured":"Sloop G, Holsworth RE Jr, Weidman JJ, St Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther Adv Cardiovasc Dis. 2015, 9:19-25. 10.1177\/1753944714553226","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/srep19603","article-title":"Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer","volume":"6","author":"Zhang Y","year":"2016","unstructured":"Zhang Y, Yang Y, Chen W, Liang L, Zhai Z, Guo L, Wang C. Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer. Sci Rep. 2016, 6:19603. 10.1038\/srep19603","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail MY","year":"2020","unstructured":"Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020, 192:40-51. 10.1016\/j.thromres.2020.05.008","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.01759","article-title":"Incidence of symptomatic venous thromboembolism after elective knee arthroscopy","volume":"94","author":"Maletis GB","year":"2012","unstructured":"Maletis GB, Inacio MC, Reynolds S, Funahashi TT. Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. J Bone Joint Surg Am. 2012, 94:714-20. 10.2106\/JBJS.J.01759","journal-title":"J Bone Joint Surg Am"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDtt2100050","article-title":"Should combined hormonal contraception be stopped in the perioperative period?","volume":"1","author":"Takvorian K","year":"2022","unstructured":"Takvorian K. Should combined hormonal contraception be stopped in the perioperative period?. NEJM Evid. 2022, 1:EVIDtt2100050. 10.1056\/EVIDtt2100050","journal-title":"NEJM Evid"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.08.061","article-title":"Withholding of hormone replacement therapy prior to total joint arthroplasty surgery to reduce the risk of postoperative thromboembolic events: is it justified? A systematic review of clinical practice guidelines","volume":"39","author":"Abouharb AL","year":"2024","unstructured":"Abouharb AL, Mehta S, Rathnayake H, Pandit H. Withholding of hormone replacement therapy prior to total joint arthroplasty surgery to reduce the risk of postoperative thromboembolic events: is it justified? A systematic review of clinical practice guidelines. J Arthroplasty. 2024, 39:541-8.e24. 10.1016\/j.arth.2023.08.061","journal-title":"J Arthroplasty"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2025.05.027","article-title":"Estrogen replacement therapy decreases associated risk of postoperative venous thromboemboli and medical complications after total joint arthroplasty","volume":"40","author":"Zhao S","year":"2025","unstructured":"Zhao S, Kelly M, Smith S, et al.. Estrogen replacement therapy decreases associated risk of postoperative venous thromboemboli and medical complications after total joint arthroplasty. J Arthroplasty. 2025, 40:2995-9.e1. 10.1016\/j.arth.2025.05.027","journal-title":"J Arthroplasty"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.21.01258","article-title":"Recommendations from the ICM-VTE: shoulder & elbow","volume":"104","author":"The ICM-VTE Shoulder & Elbow Delegates","year":"2022","unstructured":"The ICM-VTE Shoulder & Elbow Delegates. Recommendations from the ICM-VTE: shoulder & elbow. J Bone Joint Surg Am. 2022, 104:252-66. 10.2106\/JBJS.21.01258","journal-title":"J Bone Joint Surg Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter Y","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, et al.. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141:e278S-325S. 10.1378\/chest.11-2404","journal-title":"Chest"},{"key":"ref23","unstructured":"TriNetX research network. (2025). Accessed. September 1, 2025: https:\/\/trinetx.com."},{"key":"ref24","unstructured":"Current Procedural Terminology (CPT). (2025). Accessed. September 1, 2025: https:\/\/www.ama-assn.org\/practice-management\/cpt."},{"key":"ref25","unstructured":"ICD-10-CM. (2025). Accessed. September 1, 2025: https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm.htm."},{"key":"ref26","unstructured":"National Library of Medicine. RxNorm. (2025). Accessed. September 1, 2025: https:\/\/www.nlm.nih.gov\/research\/umls\/rxnorm\/."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.09.012","article-title":"The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank","volume":"230","author":"Lo Faro V","year":"2024","unstructured":"Lo Faro V, Johansson T, Johansson \u00c5. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank. Am J Obstet Gynecol. 2024, 230:360.e1-e13. 10.1016\/j.ajog.2023.09.012","journal-title":"Am J Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2020.10.025","article-title":"Combined oral contraceptive use increases the risk of venous thromboembolism after knee arthroscopy and anterior cruciate ligament reconstruction: an analysis of 64,165 patients in the Truven database","volume":"37","author":"Traven SA","year":"2021","unstructured":"Traven SA, Farley KX, Gottschalk MB, Goodloe JB, Woolf SK, Xerogeanes JW, Slone HS. Combined oral contraceptive use increases the risk of venous thromboembolism after knee arthroscopy and anterior cruciate ligament reconstruction: an analysis of 64,165 patients in the Truven database. Arthroscopy. 2021, 37:924-31. 10.1016\/j.arthro.2020.10.025","journal-title":"Arthroscopy"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.12.029","article-title":"Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials","volume":"199","author":"Ayele HT","year":"2021","unstructured":"Ayele HT, Brunetti VC, Renoux C, Tagalakis V, Filion KB. Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021, 199:123-31. 10.1016\/j.thromres.2020.12.029","journal-title":"Thromb Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point","volume":"69","author":"Bachman E","year":"2014","unstructured":"Bachman E, Travison TG, Basaria S, et al.. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014, 69:725-35. 10.1093\/gerona\/glt154","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000271","article-title":"Testosterone and the cardiovascular system: a comprehensive review of the basic science literature","volume":"2","author":"Herring MJ","year":"2013","unstructured":"Herring MJ, Oskui PM, Hale SL, Kloner RA. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013, 2:e000271. 10.1161\/JAHA.113.000271","journal-title":"J Am Heart Assoc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez C","year":"2016","unstructured":"Martinez C, Suissa S, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ. 2016, 355:i5968. 10.1136\/bmj.i5968","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.05.012","article-title":"Risk of venous thromboembolism in men receiving testosterone therapy","volume":"90","author":"Baillargeon J","year":"2015","unstructured":"Baillargeon J, Urban RJ, Morgentaler A, Glueck CJ, Baillargeon G, Sharma G, Kuo YF. Risk of venous thromboembolism in men receiving testosterone therapy. Mayo Clin Proc. 2015, 90:1038-45. 10.1016\/j.mayocp.2015.05.012","journal-title":"Mayo Clin Proc"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.10.023","article-title":"Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis","volume":"172","author":"Houghton DE","year":"2018","unstructured":"Houghton DE, Alsawas M, Barrioneuvo P, et al.. Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2018, 172:94-103. 10.1016\/j.thromres.2018.10.023","journal-title":"Thromb Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae317","article-title":"Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation","volume":"109","author":"Lanzi V","year":"2024","unstructured":"Lanzi V, Indirli R, Tripodi A, et al.. Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation. J Clin Endocrinol Metab. 2024, 109:3186-95. 10.1210\/clinem\/dgae317","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/pathophysiology30020011","article-title":"Hormone replacement therapy does not eliminate risk factors for joint complications following total joint arthroplasty: a matched cohort study","volume":"30","author":"Collins LK","year":"2023","unstructured":"Collins LK, Cole MW, Waters TL, Iloanya M, Massey PA, Sherman WF. Hormone replacement therapy does not eliminate risk factors for joint complications following total joint arthroplasty: a matched cohort study. Pathophysiology. 2023, 30:123-35. 10.3390\/pathophysiology30020011","journal-title":"Pathophysiology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-023-00620-0","article-title":"Hormone replacement therapy does not increase thrombosis risk following THA: a national database study","volume":"10","author":"McCormick BP","year":"2023","unstructured":"McCormick BP, Sequeira SB, Hasenauer MD, Boucher HR. Hormone replacement therapy does not increase thrombosis risk following THA: a national database study. J Exp Orthop. 2023, 10:60. 10.1186\/s40634-023-00620-0","journal-title":"J Exp Orthop"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2016.04.026","article-title":"Risk factors for infection after knee arthroscopy: analysis of 595,083 cases from 3 United States databases","volume":"32","author":"Clement RC","year":"2016","unstructured":"Clement RC, Haddix KP, Creighton RA, Spang JT, Tennant JN, Kamath GV. Risk factors for infection after knee arthroscopy: analysis of 595,083 cases from 3 United States databases. Arthroscopy. 2016, 32:2556-61. 10.1016\/j.arthro.2016.04.026","journal-title":"Arthroscopy"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000430","article-title":"The rate and management of prosthetic joint infection in the low-income setting: a cross-sectional study","volume":"85","author":"Hafez MA","year":"2023","unstructured":"Hafez MA, Zamel F, El-Khadrawi T, El Ganzoury I, Lotfy AM, Fansa M, Makram AM. The rate and management of prosthetic joint infection in the low-income setting: a cross-sectional study. Ann Med Surg (Lond). 2023, 85:790-5. 10.1097\/MS9.0000000000000430","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501998-evaluating-the-lack-of-association-between-preoperative-hormone-replacement-therapy-and-increased-venous-thromboembolism-after-arthroscopic-orthopedic-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:03:33Z","timestamp":1781262213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501998-evaluating-the-lack-of-association-between-preoperative-hormone-replacement-therapy-and-increased-venous-thromboembolism-after-arthroscopic-orthopedic-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.110726","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}